INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
64 hedge funds and large institutions have $36.3M invested in Infinity Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
55% less capital invested
Capital invested by funds: $80.2M → $36.3M (-$43.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holding in Top 10
–
Calls
$211K
Puts
$22K
Top Buyers
| 1 | +$2.59M | |
| 2 | +$525K | |
| 3 | +$346K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$173K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$151K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$1.25M | |
| 3 | -$988K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$771K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$745K |